Detalles de la búsqueda
1.
Long-term efficacy and safety of cladribine (2-CdA) in adult patients with mastocytosis.
Blood;
126(8): 1009-16; quiz 1050, 2015 Aug 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-26002962
2.
[Support for children of parents suffering from cancer]. / Soutenir les enfants de parents touchés par le cancer.
Soins Pediatr Pueric;
(270): 42-5, 2013.
Artículo
en Francés
| MEDLINE | ID: mdl-23379071
3.
Low-dose vs. high-dose thalidomide for advanced multiple myeloma: a prospective trial from the Intergroupe Francophone du Myélome.
Eur J Haematol;
88(3): 249-59, 2012 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-22023551
4.
Front-line high-dose chemotherapy with rituximab showed excellent long-term survival in adults with aggressive large b-cell lymphoma: final results of a Phase II GOELAMS Study.
Biol Blood Marrow Transplant;
16(5): 672-7, 2010 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-20045738
5.
Upfront VIP-reinforced-ABVD (VIP-rABVD) is not superior to CHOP/21 in newly diagnosed peripheral T cell lymphoma. Results of the randomized phase III trial GOELAMS-LTP95.
Br J Haematol;
151(2): 159-66, 2010 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-20738307
6.
Evaluation of the (R)VAD+C regimen for the treatment of newly diagnosed mantle cell lymphoma. Combined results of two prospective phase II trials from the French GOELAMS group.
Haematologica;
95(8): 1350-7, 2010 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-20220059
7.
Phase II study of bendamustine, bortezomib and dexamethasone as second-line treatment for elderly patients with multiple myeloma: the Intergroupe Francophone du Myelome 2009-01 trial.
Haematologica;
100(2): e56-9, 2015 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-25398832
8.
Masitinib for the treatment of systemic and cutaneous mastocytosis with handicap: a phase 2a study.
Am J Hematol;
85(12): 921-5, 2010 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-21108325
9.
Melphalan and prednisone plus thalidomide versus melphalan and prednisone alone or reduced-intensity autologous stem cell transplantation in elderly patients with multiple myeloma (IFM 99-06): a randomised trial.
Lancet;
370(9594): 1209-18, 2007 Oct 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-17920916
10.
Outcome of adult T-lymphoblastic lymphoma after acute lymphoblastic leukemia-type treatment: a GOELAMS trial.
Haematologica;
92(12): 1623-30, 2007 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-18055985
11.
[Clinical research activity of the French cancer cooperative network: Overview and perspectives]. / Activité de recherche clinique académique des investigateurs du réseau des Groupes coopérateurs en oncologie (GCO) : bilan et perspectives.
Bull Cancer;
104(7-8): 652-661, 2017.
Artículo
en Francés
| MEDLINE | ID: mdl-28688747
12.
Thalidomide versus placebo in myeloid metaplasia with myelofibrosis: a prospective, randomized, double-blind, multicenter study.
Haematologica;
91(8): 1027-32, 2006 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-16885042
13.
Long-term follow-up results of IFM99-03 and IFM99-04 trials comparing nonmyeloablative allotransplantation with autologous transplantation in high-risk de novo multiple myeloma.
Blood;
112(9): 3914-5, 2008 Nov 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-18948589
14.
Comparison between adult endocarditis due to beta-hemolytic streptococci (serogroups A, B, C, and G) and Streptococcus milleri: a multicenter study in France.
Arch Intern Med;
162(21): 2450-6, 2002 Nov 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-12437404
15.
Ethical and clinical aspects of intensive care unit admission in patients with hematological malignancies: guidelines of the ethics commission of the French society of hematology.
Adv Hematol;
2014: 704318, 2014.
Artículo
en Inglés
| MEDLINE | ID: mdl-25349612
16.
Exome sequencing identifies germline variants in DIS3 in familial multiple myeloma.
Leukemia;
33(9): 2324-2330, 2019 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-30967618
17.
Intermediate stage Hodgkin lymphoma in partial remission after three or four courses of doxorubicin, bleomycin, vinblastine dacarbazine: no benefit of one course of intensive chemotherapy before irradiation.
Leuk Lymphoma;
54(1): 76-82, 2013 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-22680774
18.
Superiority of the triple combination of bortezomib-thalidomide-dexamethasone over the dual combination of thalidomide-dexamethasone in patients with multiple myeloma progressing or relapsing after autologous transplantation: the MMVAR/IFM 2005-04 Randomized Phase III Trial from the Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation.
J Clin Oncol;
30(20): 2475-82, 2012 Jul 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-22585692
19.
Bortezomib plus dexamethasone is superior to vincristine plus doxorubicin plus dexamethasone as induction treatment prior to autologous stem-cell transplantation in newly diagnosed multiple myeloma: results of the IFM 2005-01 phase III trial.
J Clin Oncol;
28(30): 4621-9, 2010 Oct 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-20823406
20.
Polyarteritis nodosa and Churg-Strauss angiitis: characteristics and outcome in 38 patients over 65 years.
Medicine (Baltimore);
81(1): 27-40, 2002 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-11807403